Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis-Reference-Cited by-同舟云学术

Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis

Published:2018-10-04 Issue:1 Volume:11 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Petrusca Daniela N^ORCID,Toscani Denise,Wang Feng-Ming,Park Cheolkyu,Crean Colin D,Anderson Judith L,Marino Silvia,Mohammad Khalid S,Zhou Dan,Silbermann Rebecca,Sun Quanhong,Kurihara Noriyoshi,Galson Deborah L,Giuliani Nicola,Roodman G David

Funder

VA Merit Review

National Cancer Institute

Commonwealth of PA

American Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-018-0666-5.pdf

Reference54 articles.

1. Bianchi G, Munshi NC. Pathogenesis beyond the cancer clone(s) in multiple myeloma. Blood. 2015;125(20):3049–58.

2. Roodman GD. Multiple myeloma research F. myeloma bone disease: pathogenesis and treatment. Oncology. 2005;19(8):983–4 6.

3. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111(5):2516–20.

4. Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia. 2012;26(1):149–57.

5. D’Souza S, del Prete D, Jin S, Sun Q, Huston AJ, Kostov FE, et al. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease. Blood. 2011;118(26):6871–80.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome;Hematology;2023-06-08

2. LncRNA RP11-1100L3.8 Involves in the Pathogenesis of Multiple Myeloma by Regulating NR4A1;Discovery Medicine;2023

3. Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma;International Journal of Molecular Sciences;2022-12-07

4. A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity;International Journal of Molecular Sciences;2022-08-30

5. Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets;Frontiers in Oncology;2022-06-08